Test Cartridge News Today

09.05.2023 - Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced that it has made a De Novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue RSV Molecular Test for at-home and point-of-care ... Seite 1

The de novo submission is for a molecular diagnostic test for respiratory syncytial virus meant for home and point-of-care use.

/PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced that...